FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2165419075> ?p ?o ?g. }

• W2165419075 endingPage "259" @default.
• W2165419075 startingPage "252" @default.
• W2165419075 abstract "ABSTRACT. Chronic allograft dysfunction, which is the most common cause of late allograft failure, is in part caused by an ongoing immune response orchestrated by T lymphocytes primed by the indirect pathway of allorecognition. The low frequencies of such T cells have made it difficult to study indirect alloreactivity by using currently available assays. The development of a sensitive, clinically useful method of measuring indirect alloreactivity among human renal transplant recipients was thus attempted. Furthermore, in a pilot immunologic study, the contribution of the indirect pathway was studied in two groups of renal transplant recipients, i.e., patients with no prior acute rejection episodes and stable renal function (“stable” patients) and patients with at least one previous episode of biopsy-proven acute rejection, who were thus at risk for the development of chronic rejection (“high-risk” patients). The frequencies of type 1 T helper (interferon-γ-producing) and type 2 T helper (interleukin-5- and -10-producing) peripheral blood lymphocytes reactive with a panel of synthetic peptides (corresponding to sequences from donor HLA-DR molecules) were determined for renal transplant recipients and normal control subjects by using an enzyme-linked immunosorbent spot assay (ELISPOT). Among recipients of DR-mismatched allografts, a cut-off value of 60 interferon-γ spots/106 cells significantly (P = 0.02) separated stable patients (creatinine concentration, 1.1 ± 0.3 mg/dl) from high-risk patients (creatinine concentration, 2.3 ± 1.7 mg/dl). This is the first demonstration that the enzyme-linked immunosorbent spot assay can be used to monitor indirect alloreactivity to donor HLA-DR peptides among renal transplant recipients. These data provide the rationale for the prospective study of indirect alloreactivity among transplant recipients, to allow predictions of which patients would be at risk for the development of chronic rejection and thus allow appropriate planning of future interventions." @default.
• W2165419075 created "2016-06-24" @default.
• W2165419075 creator A5002197635 @default.
• W2165419075 creator A5005037626 @default.
• W2165419075 creator A5028211848 @default.
• W2165419075 creator A5037972566 @default.
• W2165419075 creator A5045774777 @default.
• W2165419075 date "2002-01-01" @default.
• W2165419075 modified "2023-10-05" @default.
• W2165419075 title "Enzyme-Linked Immunosorbent Spot Assay Analysis of Peripheral Blood Lymphocyte Reactivity to Donor HLA-DR Peptides" @default.
• W2165419075 cites W1935012135 @default.
• W2165419075 cites W1991562873 @default.
• W2165419075 cites W1998243760 @default.
• W2165419075 cites W1999949997 @default.
• W2165419075 cites W2000620661 @default.
• W2165419075 cites W2003354598 @default.
• W2165419075 cites W2008999841 @default.
• W2165419075 cites W2009236577 @default.
• W2165419075 cites W2011605997 @default.
• W2165419075 cites W2012447761 @default.
• W2165419075 cites W2014452295 @default.
• W2165419075 cites W2018492373 @default.
• W2165419075 cites W2021588424 @default.
• W2165419075 cites W2023342293 @default.
• W2165419075 cites W2025123869 @default.
• W2165419075 cites W2029116084 @default.
• W2165419075 cites W2043763796 @default.
• W2165419075 cites W2048571115 @default.
• W2165419075 cites W2048574215 @default.
• W2165419075 cites W2052445800 @default.
• W2165419075 cites W2084606466 @default.
• W2165419075 cites W2085296338 @default.
• W2165419075 cites W2087954296 @default.
• W2165419075 cites W2089742319 @default.
• W2165419075 cites W2100422482 @default.
• W2165419075 cites W2143446060 @default.
• W2165419075 cites W2145594595 @default.
• W2165419075 cites W2160205722 @default.
• W2165419075 cites W2333378480 @default.
• W2165419075 cites W4250399467 @default.
• W2165419075 doi "https://doi.org/10.1681/asn.v131252" @default.
• W2165419075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11752045" @default.
• W2165419075 hasPublicationYear "2002" @default.
• W2165419075 type Work @default.
• W2165419075 sameAs 2165419075 @default.
• W2165419075 citedByCount "116" @default.
• W2165419075 countsByYear W21654190752012 @default.
• W2165419075 countsByYear W21654190752013 @default.
• W2165419075 countsByYear W21654190752014 @default.
• W2165419075 countsByYear W21654190752015 @default.
• W2165419075 countsByYear W21654190752016 @default.
• W2165419075 countsByYear W21654190752017 @default.
• W2165419075 countsByYear W21654190752018 @default.
• W2165419075 countsByYear W21654190752019 @default.
• W2165419075 countsByYear W21654190752020 @default.
• W2165419075 countsByYear W21654190752021 @default.
• W2165419075 countsByYear W21654190752022 @default.
• W2165419075 countsByYear W21654190752023 @default.
• W2165419075 crossrefType "journal-article" @default.
• W2165419075 hasAuthorship W2165419075A5002197635 @default.
• W2165419075 hasAuthorship W2165419075A5005037626 @default.
• W2165419075 hasAuthorship W2165419075A5028211848 @default.
• W2165419075 hasAuthorship W2165419075A5037972566 @default.
• W2165419075 hasAuthorship W2165419075A5045774777 @default.
• W2165419075 hasBestOaLocation W21654190751 @default.
• W2165419075 hasConcept C126322002 @default.
• W2165419075 hasConcept C147483822 @default.
• W2165419075 hasConcept C188280979 @default.
• W2165419075 hasConcept C200315206 @default.
• W2165419075 hasConcept C203014093 @default.
• W2165419075 hasConcept C207936829 @default.
• W2165419075 hasConcept C2776090121 @default.
• W2165419075 hasConcept C2777761686 @default.
• W2165419075 hasConcept C2779053233 @default.
• W2165419075 hasConcept C2780306776 @default.
• W2165419075 hasConcept C71924100 @default.
• W2165419075 hasConcept C8891405 @default.
• W2165419075 hasConceptScore W2165419075C126322002 @default.
• W2165419075 hasConceptScore W2165419075C147483822 @default.
• W2165419075 hasConceptScore W2165419075C188280979 @default.
• W2165419075 hasConceptScore W2165419075C200315206 @default.
• W2165419075 hasConceptScore W2165419075C203014093 @default.
• W2165419075 hasConceptScore W2165419075C207936829 @default.
• W2165419075 hasConceptScore W2165419075C2776090121 @default.
• W2165419075 hasConceptScore W2165419075C2777761686 @default.
• W2165419075 hasConceptScore W2165419075C2779053233 @default.
• W2165419075 hasConceptScore W2165419075C2780306776 @default.
• W2165419075 hasConceptScore W2165419075C71924100 @default.
• W2165419075 hasConceptScore W2165419075C8891405 @default.
• W2165419075 hasIssue "1" @default.
• W2165419075 hasLocation W21654190751 @default.
• W2165419075 hasOpenAccess W2165419075 @default.
• W2165419075 hasPrimaryLocation W21654190751 @default.
• W2165419075 hasRelatedWork W1506984959 @default.
• W2165419075 hasRelatedWork W1989855601 @default.
• W2165419075 hasRelatedWork W2007015176 @default.
• W2165419075 hasRelatedWork W2035319065 @default.
• W2165419075 hasRelatedWork W2043325088 @default.

• next